The genetic effect on omega 3 fatty acid supplementation for the treatment of non alcoholic fatty liver disease in obese children and adolescents

Conditions

Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1 | Hypertriglyceridemia | Non Alcoholic Fatty Liver Disease | Steatohepatitis

What is the purpose of this trial?

To explore whether there is a different response to the omega-3 fatty acid supplementation vs omega-3 fatty acid rich diet with respect to the hepatic fat fraction % (HFF), triglyceride, and ALT levels between the rs738409 minor allele (GG) and the common allele homozygous (CC) of PNPLA3.


Participation Guidelines

Age:
10 Years - 19 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University School of Medicine
Dates:
05/03/2012
Last Updated:
Study HIC#:
1112009408